Fujifilm's CDMO carves foothold in Boston biotech hub with new HQ focused on viral vectors, gene therapies
On the heels of a red-letter year for contract manufacturers, Japan’s Fujifilm has seen its CDMO arm — Fujifilm Diosynth Biotechnologies — earn interest from major Covid …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
